#pregnancytok #baby #mommy #fallbabies🍁🎃👻❤️ #summermashup #cholestasisawareness #thirdtrimesterproblems #fyp #parati #foryouu I found out yesterday that my aunt & cousins were throwing me a surprise baby shower but I accidentally ruined the surprise lol. One of my cousins, who just had her baby in April, told me to tell my OB about an intense itchiness I was having in my hands & feet bc it could potentially be a liver condition that is harmful to the baby, called cholestasis. If I do have it, I’ll be delivering about 5 weeks earlier than we’re expecting. I spoke with my OB she immediately requested more labs after we discussed my symptoms. It could be super dry skin or it could be cholestasis. So, I had updated my cousin about my prenatal appointment & she ended up telling me about the surprise party that her mom, her sister & her had been planning. It made me tear up bc I wasn’t expecting them to throw me a baby shower. I’m so thankful for the family I am close with… ✨♥️ Other than that, baby is now in a downward position facing my spine, is very healthy & measuring at 2 lbs 14 oz. I’ll know in a week if I’ll be getting induced early.
Cholestasis of pregnancy, also known as intrahepatic cholestasis of pregnancy (ICP), is a liver condition that affects some pregnant women, particularly in the third trimester. It is characterized by intense itching, especially on the hands and feet, without a rash. This condition occurs due to disrupted bile flow, which can cause bile acids to accumulate in the bloodstream and affect the baby. Cholestasis is important to recognize and monitor because it can increase the risks of premature birth, fetal distress, and, in severe cases, stillbirth. If symptoms like severe itching arise, it is crucial to consult an obstetrician promptly for diagnostic testing that usually includes liver function tests and bile acid measurements. Management of cholestasis typically involves close monitoring of both mother and baby, including frequent ultrasounds and non-stress tests. Early delivery—often by induction—is commonly recommended around 36 to 37 weeks to reduce risks to the baby. Treatments may also include medications like ursodeoxycholic acid to alleviate symptoms and lower bile acid levels. For expectant mothers experiencing symptoms linked to cholestasis, maintaining open communication with healthcare providers is essential. Recognizing symptoms early can help ensure timely interventions that promote the best possible outcome for both mother and baby. Additionally, the emotional aspect of pregnancy, such as unexpected surprises like baby showers, plays a vital role in maternal well-being. Support from family and loved ones strengthens resilience during complicated pregnancies and adds to the joy of welcoming a new life. Understanding both the medical and emotional experiences around cholestasis and pregnancy highlights the importance of comprehensive prenatal care. Awareness and preparedness can empower pregnant women facing similar challenges to navigate their pregnancy with confidence and hope.
